What’s new in the renin-angiotensin system?
Identifieur interne : 005A52 ( Main/Merge ); précédent : 005A51; suivant : 005A53What’s new in the renin-angiotensin system?
Auteurs : F. J. Warner [Royaume-Uni, Australie] ; A. I. Smith [Australie] ; N. M. Hooper [Royaume-Uni] ; A. J. Turner [Royaume-Uni]Source :
- Cellular and Molecular Life Sciences CMLS [ 1420-682X ] ; 2004-11-01.
English descriptors
- KwdEn :
Abstract
Abstract.: Angiotensin-converting enzyme-2 (ACE2) is the first human homologue of ACE to be described. ACE2 is a type I integral membrane protein which functions as a carboxypeptidase, cleaving a single hydrophobic/basic residue from the C-terminus of its substrates. ACE2 efficiently hydrolyses the potent vasoconstrictor angiotensin II to angiotensin (1–7). It is a consequence of this action that ACE2 participates in the renin-angiotensin system. However, ACE2 also hydrolyses dynorphin A (1–13), apelin-13 and des-Arg9 bradykinin. The role of ACE2 in these peptide systems has yet to be revealed. A physiological role for ACE2 has been implicated in hypertension, cardiac function, heart function and diabetes, and as a receptor of the severe acute respiratory syndrome coronavirus. This paper reviews the biochemistry of ACE2 and discusses key findings such as the elucidation of crystal structures for ACE2 and testicular ACE and the development of ACE2 inhibitors that have now provided a basis for future research on this enzyme.
Url:
DOI: 10.1007/s00018-004-4240-7
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001624
- to stream Istex, to step Curation: 001624
- to stream Istex, to step Checkpoint: 001C84
Links to Exploration step
ISTEX:577CE89A077B358AAB9A1CB1132D3F463F48C464Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">What’s new in the renin-angiotensin system?</title><author><name sortKey="Warner, F J" sort="Warner, F J" uniqKey="Warner F" first="F. J." last="Warner">F. J. Warner</name></author><author><name sortKey="Smith, A I" sort="Smith, A I" uniqKey="Smith A" first="A. I." last="Smith">A. I. Smith</name></author><author><name sortKey="Hooper, N M" sort="Hooper, N M" uniqKey="Hooper N" first="N. M." last="Hooper">N. M. Hooper</name></author><author><name sortKey="Turner, A J" sort="Turner, A J" uniqKey="Turner A" first="A. J." last="Turner">A. J. Turner</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:577CE89A077B358AAB9A1CB1132D3F463F48C464</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1007/s00018-004-4240-7</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-55WCR426-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001624</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001624</idno><idno type="wicri:Area/Istex/Curation">001624</idno><idno type="wicri:Area/Istex/Checkpoint">001C84</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001C84</idno><idno type="wicri:doubleKey">1420-682X:2004:Warner F:what:s:new</idno><idno type="wicri:Area/Main/Merge">005A52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">What’s new in the renin-angiotensin system?</title><author><name sortKey="Warner, F J" sort="Warner, F J" uniqKey="Warner F" first="F. J." last="Warner">F. J. Warner</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Biochemistry and Microbiology, University of Leeds, LS2 9JT, Leeds</wicri:regionArea><orgName type="university">Université de Leeds</orgName><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Baker Heart Research Institute, St Kilda Rd Central, P.O. 6492, 8008, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Australie</country></affiliation></author><author><name sortKey="Smith, A I" sort="Smith, A I" uniqKey="Smith A" first="A. I." last="Smith">A. I. Smith</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>Baker Heart Research Institute, St Kilda Rd Central, P.O. 6492, 8008, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Hooper, N M" sort="Hooper, N M" uniqKey="Hooper N" first="N. M." last="Hooper">N. M. Hooper</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Biochemistry and Microbiology, University of Leeds, LS2 9JT, Leeds</wicri:regionArea><orgName type="university">Université de Leeds</orgName><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName></affiliation></author><author><name sortKey="Turner, A J" sort="Turner, A J" uniqKey="Turner A" first="A. J." last="Turner">A. J. Turner</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Biochemistry and Microbiology, University of Leeds, LS2 9JT, Leeds</wicri:regionArea><orgName type="university">Université de Leeds</orgName><placeName><settlement type="city">Leeds</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Yorkshire-et-Humber</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Cellular and Molecular Life Sciences CMLS</title><title level="j" type="abbrev">CMLS, Cell. Mol. Life Sci.</title><idno type="ISSN">1420-682X</idno><idno type="eISSN">1420-9071</idno><imprint><publisher>Birkhäuser-Verlag; www.birkhauser.ch</publisher><pubPlace>Basel</pubPlace><date type="published" when="2004-11-01">2004-11-01</date><biblScope unit="volume">61</biblScope><biblScope unit="issue">21</biblScope><biblScope unit="page" from="2704">2704</biblScope><biblScope unit="page" to="2713">2713</biblScope></imprint><idno type="ISSN">1420-682X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1420-682X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ACE2</term><term>Angiotensin converting enzyme</term><term>carboxypeptidase</term><term>peptidase</term><term>renin-angiotensin system</term><term>structure</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract.: Angiotensin-converting enzyme-2 (ACE2) is the first human homologue of ACE to be described. ACE2 is a type I integral membrane protein which functions as a carboxypeptidase, cleaving a single hydrophobic/basic residue from the C-terminus of its substrates. ACE2 efficiently hydrolyses the potent vasoconstrictor angiotensin II to angiotensin (1–7). It is a consequence of this action that ACE2 participates in the renin-angiotensin system. However, ACE2 also hydrolyses dynorphin A (1–13), apelin-13 and des-Arg9 bradykinin. The role of ACE2 in these peptide systems has yet to be revealed. A physiological role for ACE2 has been implicated in hypertension, cardiac function, heart function and diabetes, and as a receptor of the severe acute respiratory syndrome coronavirus. This paper reviews the biochemistry of ACE2 and discusses key findings such as the elucidation of crystal structures for ACE2 and testicular ACE and the development of ACE2 inhibitors that have now provided a basis for future research on this enzyme.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005A52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005A52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:577CE89A077B358AAB9A1CB1132D3F463F48C464
|texte= What’s new in the renin-angiotensin system?
}}
| This area was generated with Dilib version V0.6.33. |  |